| |
| |
|
| Insider
Information: |
Klein Joseph III |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
86,717 |
|
|
Indirect Shares
|
111 |
|
|
| Direct
Value |
$3,758,117 |
|
|
|
Indirect Value
|
$3,784 |
|
|
| Total
Shares |
86,828 |
|
|
| Total
Value |
$3,761,901 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
3
|
|
Stock
price went up :
|
2
|
0
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
2.0
|
-3.0
|
| Percentage
Gain/Loss : |
 127.5%
|
 -83.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
NPS Pharmaceuticals Inc |
NPSP |
as of May 22, 2007 |
2007-05-23 |
0 |
2003-09-11 |
0 |
Premium* |
|
|
Biomarin Pharmaceutical Inc |
BMRN |
Director |
2010-03-08 |
35,000 |
2007-03-07 |
0 |
Premium* |
|
|
Clinical Data Inc |
CLDA |
Former Director |
2006-10-11 |
1,000 |
|
0 |
Premium* |
|
|
Ionis Pharmaceuticals Inc |
IONS |
Director |
2024-05-03 |
16,346 |
2024-05-03 |
100 |
Premium* |
|
|
Savient Pharmaceuticals Inc |
SVNTQ |
Director |
2010-06-08 |
17,388 |
2006-06-01 |
0 |
Premium* |
|
|
PDL Biopharma Inc |
PDLI |
Director |
2009-11-04 |
16,983 |
2009-11-04 |
11 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
178 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 6 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SVNTQ |
Savient Pharmaceuticals I... |
Director |
– • – |
2010-06-08 |
4 |
A |
$11.38 |
$39,989 |
D/D |
3,514 |
17,388 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Director |
– • – |
2023-07-18 |
4 |
AS |
$42.00 |
$149,310 |
D/D |
(3,555) |
20,346 |
0 |
% |
|
| CLDA |
Clinical Data Inc |
Former Director |
– – – |
2006-09-26 |
4 |
S |
$14.63 |
$52,650 |
D/D |
(3,600) |
3,371 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Director |
– • – |
2013-03-20 |
4 |
OE |
$5.93 |
$53,357 |
I/I |
3,924 |
174 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Director |
– • – |
2013-03-20 |
4 |
AS |
$18.00 |
$70,632 |
I/I |
(3,924) |
0 |
0 |
- |
|
| CLDA |
Clinical Data Inc |
officerTitle |
– • – |
2005-12-23 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
11,062 |
|
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
Director |
– • – |
2008-05-01 |
4 |
S |
$21.71 |
$86,840 |
D/D |
(4,000) |
24,804 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
Director |
– • – |
2008-05-05 |
4 |
S |
$23.90 |
$95,600 |
D/D |
(4,000) |
20,804 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
Director |
– • – |
2008-05-12 |
4 |
S |
$24.59 |
$98,360 |
D/D |
(4,000) |
16,804 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
Director |
– • – |
2008-05-19 |
4 |
S |
$22.67 |
$90,680 |
D/D |
(4,000) |
14,426 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
Director |
– • – |
2008-05-27 |
4 |
S |
$24.07 |
$96,280 |
D/D |
(4,000) |
10,426 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
Director |
– • – |
2008-06-02 |
4 |
S |
$26.47 |
$105,880 |
D/D |
(4,000) |
6,426 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Director |
– • – |
2021-07-15 |
4 |
AS |
$35.30 |
$152,989 |
D/D |
(4,334) |
18,126 |
0 |
% |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2009-03-03 |
4 |
B |
$10.56 |
$52,818 |
D/D |
5,000 |
37,500 |
2.39 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2009-03-05 |
4 |
B |
$10.07 |
$50,363 |
D/D |
5,000 |
42,500 |
2.39 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Director |
– • – |
2013-11-25 |
4 |
S |
$36.86 |
$221,156 |
D/D |
(6,000) |
2,313 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Director |
– • – |
2024-05-03 |
4 |
S |
$42.55 |
$256,277 |
I/I |
(6,000) |
0 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
Director |
– • – |
2015-11-11 |
4 |
S |
$64.18 |
$441,234 |
D/D |
(6,875) |
5,543 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Director |
– • – |
2015-11-11 |
4 |
OE |
$9.30 |
$75,313 |
D/D |
6,875 |
8,668 |
0 |
- |
|
| PDLI |
PDL Biopharma Inc |
Director |
– • – |
2009-06-04 |
4 |
A |
$7.16 |
$49,998 |
D/D |
6,983 |
16,983 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Director |
– • – |
2015-03-05 |
4 |
S |
$70.95 |
$496,682 |
D/D |
(7,000) |
4,095 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Director |
– • – |
2023-07-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,110 |
23,901 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
Director |
– • – |
2009-05-05 |
4 |
A |
$5.37 |
$39,996 |
D/D |
7,448 |
13,874 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Director |
– • – |
2022-07-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,998 |
20,124 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Director |
– • – |
2021-07-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,666 |
22,460 |
0 |
- |
|
178 Records found
|
|
Page 6 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
